Clinical Trials

Introduction to Clinical Trials

This is a selection of our current Clinical Trials.

Eisai - Mission AD Trial 

Mild Cognitive Impairment & Early AD).  Investigating the effectiveness and safety of a  tablet drug, Elenbecestat (E2609) aiming to reduce amyloid build up



  • 50-85 yrs 
  • MMSE 24+
  • Study partner/ caregiver
  • CDR score of 0.5
  • Dose stable on cholinesterase inhibitors for 12 weeks prior to baseline
  • Patients with AD  currently not on  any medication  are suitable
  • History of Seizures within last 5 years 
  • History of TIA or strokes within last 12 months
  • Contraindications for MRI
  • History of malignant neoplasms within last 5 years
  • Have any evidence  that could indicate a dementia   diagnosis other than AD on brain MRI
Contact us for further information

Cookies on our website

Cookies are used to ensure you get the best browsing experience. No personally identifiable information is collected.
By using our site you agree to these cookies being used. For more information please see our Cookie Policy.